Leukopenia News and Research

RSS
Leukopenia is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.
Pfizer reports final results from randomized Phase 3 trial of Sutent

Pfizer reports final results from randomized Phase 3 trial of Sutent

VELCADE sNDA receives FDA approval

VELCADE sNDA receives FDA approval

Colcrys Patient Assistance Program introduced by URL Pharma

Colcrys Patient Assistance Program introduced by URL Pharma

INS cites FDA-approved Totect antidote for anthracycline extravasations

INS cites FDA-approved Totect antidote for anthracycline extravasations

ZYPREXA RELPREVV approved by FDA

ZYPREXA RELPREVV approved by FDA

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

Schizophrenia: Once-monthly INVEGA SUSTENNA not inferior to bi-weekly RISPERDAL CONSTA

VERTICAL Phase II trial results for NHL released

VERTICAL Phase II trial results for NHL released

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Micromet to present new data from its blinatumomab Phase 1 trial at the ASH meeting

Micromet to present new data from its blinatumomab Phase 1 trial at the ASH meeting

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Positive data from Gloucester Pharmaceuticals' ISTODAX study presented at the ASH meeting

Presentation of preclinical data demonstrating the combination of ISTODAX and Velcade announced

Presentation of preclinical data demonstrating the combination of ISTODAX and Velcade announced

VELCADE based regimens are cost-effective for payers and patients, finds study

VELCADE based regimens are cost-effective for payers and patients, finds study

Positive final data from Phase 2 study of ISTODAX presented

Positive final data from Phase 2 study of ISTODAX presented

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

FDA approves once-daily SEROQUEL XR Extended Release Tablets

FDA approves once-daily SEROQUEL XR Extended Release Tablets

ISTODAX included in the updated NCCN Clinical Practice Guidelines in Oncology

ISTODAX included in the updated NCCN Clinical Practice Guidelines in Oncology

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

FDA approves sNDA for pediatric autism drug ABILIFY

FDA approves sNDA for pediatric autism drug ABILIFY

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from CIMZIA WELCOME trial to be presented at the ACG meeting

New data from efficacy study of CIMZIA in Crohn's disease patients presented

New data from efficacy study of CIMZIA in Crohn's disease patients presented